Proactive Investors - Run By Investors For Investors

Phoenix Molecular to start clinical trials to battle deadly form of breast cancer

"Phoenix Molecular Designs CEO Sandi Dunn joined Christine Corrado from Proactive Investors at the 11th Annual BioTech Showcase in San Francisco.
The Vancouver-based company focuses on treating triple negative breast cancer, one of the most aggressive types of breast cancer with few treatment options.

View full PHOEN profile View Profile

Phoenix Molecular Designs Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use